Microalgae DHA Opportunity to engage Martek in partnerships or licensing discussions around DHA-rich algal oils, targeting infant nutrition and life-stage wellness markets where their patented fermentation strains could enhance product portfolios.

Strategic Partnerships Leverage recent asset sale activity to propose collaboration with Martek on manufacturing, supply chain optimization, or co-development of niche nutraceuticals, aligning with their fermentation expertise and R&D expansion goals.

Growth Footprint Market expansion potential through Martek’s global reach (headquartered in Maryland with facilities in multiple states and worldwide staff) to explore contract manufacturing, white-label formulations, or regional distribution arrangements.

Tech & IP Leverage Highlight opportunities to integrate Martek’s microalgae-derived DHA and ARA platforms with clients’ product pipelines via technology licensing, process optimization, or joint R&D programs to accelerate time-to-market.

Financial Readiness With a revenue range of $50–100 million and a mid-sized employee base, position value-driven proposals focusing on cost-effective partnerships, scalable production, and risk-sharing arrangements appealing to Martek’s growth and sustainability focus.